Trial Profile
Cross-sectional study to evaluate the tocilizumab serum levels and its association with drug dosage and disease activity in rheumatoid arthritis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Pharmacokinetics
- 22 Jul 2015 New trial record